Liquid Biopsy-Based Biomarkers of Treatment Response and Resistance

Author:

Kilgour Elaine,Rothwell Dominic G.,Brady Ged,Dive Caroline

Funder

CRUK

Manchester CRUK Centre Award

CRUK Manchester Experimental Cancer Medicines Centre

CRUK Lung Cancer Centre of Excellence

AstraZeneca

Astex Pharmaceuticals

Bioven

Amgen

Carrick Therapeutics

Merck AG

Taiho Oncology

Clearbridge Biomedics

Angle PLC

Menarini Diagnostics

GSK

Bayer

Boehringer Ingelheim

Roche

BMS

Novartis

Celgene

Thermo Fisher

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference112 articles.

1. Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution;Abbosh;Nature,2017

2. Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer;Allison Stewart;Nat. Cancer,2020

3. Dynamics of tumor and immune responses during immune checkpoint blockade in non-small cell lung cancer;Anagnostou;Cancer Res.,2019

4. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay;Baccelli;Nat. Biotechnol.,2013

5. Detection of circulating tumor DNA in early- and late-stage human malignancies;Bettegowda;Sci. Transl. Med.,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3